Top 100 Contractors in NAICS 325412: Pharmaceutical Preparation Manufacturing, Jul 2025–Jun 2026

Parent companies by net contract obligations Jul 1, 2025 – Jun 30, 2026 Code page on GovTribe

The top 10 won 95% of NAICS 325412 contract dollars from July 2025 through June 2026

Ranking facts

Contract obligations
$14,339,270,857 Net of deobligations, by contracts coded NAICS 325412
Contractors
269 Parent companies with an obligation
Largest contractor
Mckesson Corporation $13.2 billion, 90.5% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $13,198,253,033
Rank history: #1 in FY2021, #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since Jul 2024–Jun 2025.
2 $170,169,845
Rank history: not on the FY2021–FY2024 lists and #5 in FY2025; up 6 since Jul 2024–Jun 2025.
3 $113,641,157
Rank history: not on the FY2021 list, #13 in FY2022, #8 in FY2023, #6 in FY2024 and #26 in FY2025; up 2 since Jul 2024–Jun 2025.
4 $107,354,431
Rank history: not on the FY2021–FY2024 lists and #8 in FY2025; up 2 since Jul 2024–Jun 2025.
5 $93,536,123
Rank history: #16 in FY2021, #14 in FY2022, #7 in FY2023, #7 in FY2024 and #6 in FY2025; up 2 since Jul 2024–Jun 2025.
6 $50,162,464
Rank history: not on the FY2021 list, #16 in FY2022, #14 in FY2023, #18 in FY2024 and #13 in FY2025; up 3 since Jul 2024–Jun 2025.
7
Meridian Medical Technologies LLC
$46,041,826
Rank history: not on the FY2021–FY2023 lists, #11 in FY2024 and #11 in FY2025; up 6 since Jul 2024–Jun 2025.
8 $45,647,185
Rank history: not on the FY2021–FY2023 lists, #8 in FY2024 and #9 in FY2025; new, not ranked in Jul 2024–Jun 2025.
9 $42,095,197
Rank history: not on the FY2021–FY2023 lists, #13 in FY2024 and #12 in FY2025; up 3 since Jul 2024–Jun 2025.
10 $39,121,602
Rank history: not on the FY2021 list, #27 in FY2022, #13 in FY2023, #14 in FY2024 and #14 in FY2025; up 6 since Jul 2024–Jun 2025.
11 $38,878,149
Rank history: not on the FY2021–FY2023 lists, #10 in FY2024 and not on the FY2025 list; new, not ranked in Jul 2024–Jun 2025.
12 $36,255,004
Rank history: not on the FY2021–FY2024 lists and #7 in FY2025; down 2 since Jul 2024–Jun 2025.
13 $33,119,794
Rank history: not on the FY2021 list, #12 in FY2022, #22 in FY2023, not on the FY2024 list and #4 in FY2025; down 2 since Jul 2024–Jun 2025.
14 $29,998,678
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Jul 2024–Jun 2025.
15 $28,713,134
Rank history: not on the FY2021–FY2024 lists and #17 in FY2025; up 3 since Jul 2024–Jun 2025.
16 $25,350,928
Rank history: #23 in FY2021, #24 in FY2022, #11 in FY2023, #16 in FY2024 and #15 in FY2025; down 1 since Jul 2024–Jun 2025.
17 $20,946,416
Rank history: #21 in FY2021, not on the FY2022–FY2024 lists and #16 in FY2025; new, not ranked in Jul 2024–Jun 2025.
18
Sagent Pharmaceuticals Inc.
$16,638,758
Rank history: not on the FY2021–FY2024 lists and #18 in FY2025; new, not ranked in Jul 2024–Jun 2025.
19 $15,715,659
Rank history: not on the FY2021–FY2022 lists, #28 in FY2023, not on the FY2024 list and #19 in FY2025; up 135 since Jul 2024–Jun 2025.
20 $15,587,920
Rank history: not on the FY2021–FY2023 lists, #15 in FY2024 and #20 in FY2025; down 6 since Jul 2024–Jun 2025.
21 $10,277,013
Rank history: #65 in FY2021, #48 in FY2022, #32 in FY2023, #33 in FY2024 and #33 in FY2025; up 13 since Jul 2024–Jun 2025.
22 $9,786,388
Rank history: #5 in FY2021, #5 in FY2022, #43 in FY2023, #31 in FY2024 and #23 in FY2025; up 47 since Jul 2024–Jun 2025.
23 $9,313,772
Rank history: not on the FY2021–FY2023 lists, #49 in FY2024 and #21 in FY2025; down 1 since Jul 2024–Jun 2025.
24 $8,700,000
Rank history: not on the FY2021–FY2023 lists, #22 in FY2024 and #24 in FY2025; down 4 since Jul 2024–Jun 2025.
25 $8,099,930
Rank history: not on the FY2021 list, #45 in FY2022, not on the FY2023–FY2024 lists and #27 in FY2025; new, not ranked in Jul 2024–Jun 2025.
26 $7,615,500
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Jul 2024–Jun 2025.
27 $6,860,720
Rank history: not on the FY2021–FY2024 lists and #25 in FY2025; up 13 since Jul 2024–Jun 2025.
28 $6,761,736
Rank history: not on the FY2021–FY2023 lists, #38 in FY2024 and #29 in FY2025; down 2 since Jul 2024–Jun 2025.
29 $6,211,955
Rank history: not on the FY2021–FY2023 lists, #68 in FY2024 and #39 in FY2025; up 9 since Jul 2024–Jun 2025.
30 $5,236,790
Rank history: not on the FY2021–FY2023 lists, #25 in FY2024 and #36 in FY2025; up 189 since Jul 2024–Jun 2025.
31 $4,974,870
Rank history: not on the FY2021–FY2024 lists and #34 in FY2025; new, not ranked in Jul 2024–Jun 2025.
32 $4,962,492
Rank history: not on the FY2021–FY2023 lists, #75 in FY2024 and #41 in FY2025; up 9 since Jul 2024–Jun 2025.
33 $4,414,034
Rank history: #50 in FY2021, #55 in FY2022, #27 in FY2023, #32 in FY2024 and #32 in FY2025; down 3 since Jul 2024–Jun 2025.
34 $4,386,498
Rank history: #61 in FY2021, #64 in FY2022, #42 in FY2023, #52 in FY2024 and #61 in FY2025; up 20 since Jul 2024–Jun 2025.
35 $4,202,585
Rank history: not on the FY2021–FY2023 lists, #44 in FY2024 and #43 in FY2025; down 3 since Jul 2024–Jun 2025.
36 $3,660,418
Rank history: #31 in FY2021, #38 in FY2022, #18 in FY2023, #30 in FY2024 and #37 in FY2025; down 3 since Jul 2024–Jun 2025.
37 $3,013,519
Rank history: #39 in FY2021, #41 in FY2022, #23 in FY2023, #35 in FY2024 and #30 in FY2025; down 9 since Jul 2024–Jun 2025.
38 $2,933,152
Rank history: not on the FY2021–FY2023 lists, #12 in FY2024 and #90 in FY2025; down 21 since Jul 2024–Jun 2025.
39 $2,871,631
Rank history: not on the FY2021–FY2023 lists, #4 in FY2024 and #40 in FY2025; down 35 since Jul 2024–Jun 2025.
40 $2,736,575
Rank history: not on the FY2021 list, #99 in FY2022, #68 in FY2023, #39 in FY2024 and #45 in FY2025; up 3 since Jul 2024–Jun 2025.
41 $2,554,326
Rank history: #32 in FY2021, #26 in FY2022, #74 in FY2023, not on the FY2024 list and #42 in FY2025; down 10 since Jul 2024–Jun 2025.
42 $2,460,000
Rank history: not on the FY2021–FY2025 lists; up 220 since Jul 2024–Jun 2025.
43 $2,147,586
Rank history: not on the FY2021–FY2024 lists and #46 in FY2025; up 9 since Jul 2024–Jun 2025.
44 $2,002,583
Rank history: not on the FY2021–FY2023 lists, #82 in FY2024 and #66 in FY2025; up 3 since Jul 2024–Jun 2025.
45 $1,979,304
Rank history: not on the FY2021–FY2022 lists, #33 in FY2023, #65 in FY2024 and #51 in FY2025; up 21 since Jul 2024–Jun 2025.
46 $1,961,380
Rank history: #29 in FY2021, #40 in FY2022, #38 in FY2023, #64 in FY2024 and #55 in FY2025; up 5 since Jul 2024–Jun 2025.
47
American Regent Inc
$1,808,157
Rank history: not on the FY2021–FY2022 lists, #93 in FY2023, #87 in FY2024 and #50 in FY2025; up 38 since Jul 2024–Jun 2025.
48 $1,766,423
Rank history: #44 in FY2021, #1 in FY2022, #2 in FY2023, not on the FY2024 list and #48 in FY2025; new, not ranked in Jul 2024–Jun 2025.
49 $1,662,810
Rank history: #14 in FY2021, not on the FY2022 list, #83 in FY2023, #99 in FY2024 and #63 in FY2025; up 42 since Jul 2024–Jun 2025.
50
Jubilant Hollisterstier LLC 2 awardees, including Jubilant Draximage Inc.
$1,580,672
Rank history: not on the FY2021–FY2024 lists and #67 in FY2025; up 10 since Jul 2024–Jun 2025.
51
UIC Parent Corporation Through Curia Global Inc.
$1,548,154
Rank history: not on the FY2021–FY2022 lists, #59 in FY2023, not on the FY2024 list and #53 in FY2025; up 12 since Jul 2024–Jun 2025.
52 $1,522,263
Rank history: #53 in FY2021, #74 in FY2022, not on the FY2023 list, #63 in FY2024 and #82 in FY2025; up 23 since Jul 2024–Jun 2025.
53 $1,379,411
Rank history: #70 in FY2021, #70 in FY2022, #49 in FY2023, #43 in FY2024 and #75 in FY2025; up 14 since Jul 2024–Jun 2025.
54 $1,342,725
Rank history: #80 in FY2021, #69 in FY2022, #47 in FY2023, #50 in FY2024 and #97 in FY2025; up 49 since Jul 2024–Jun 2025.
55 $1,323,315
Rank history: #48 in FY2021, #50 in FY2022, #70 in FY2023, #37 in FY2024 and #38 in FY2025; down 19 since Jul 2024–Jun 2025.
56 $1,257,796
Rank history: #60 in FY2021, #66 in FY2022, #55 in FY2023, #61 in FY2024 and #54 in FY2025; down 7 since Jul 2024–Jun 2025.
57 $1,200,987
Rank history: #35 in FY2021, #62 in FY2022, #45 in FY2023, #83 in FY2024 and #52 in FY2025; down 1 since Jul 2024–Jun 2025.
58 $1,127,754
Rank history: not on the FY2021–FY2025 lists; up 88 since Jul 2024–Jun 2025.
59 $1,036,397
Rank history: not on the FY2021–FY2024 lists and #76 in FY2025; unchanged since Jul 2024–Jun 2025.
60 $1,004,994
Rank history: not on the FY2021–FY2024 lists and #28 in FY2025; down 33 since Jul 2024–Jun 2025.
61 $959,715
Rank history: not on the FY2021–FY2022 lists, #81 in FY2023, not on the FY2024 list and #71 in FY2025; up 4 since Jul 2024–Jun 2025.
62 $951,872
Rank history: not on the FY2021 list, #91 in FY2022, not on the FY2023 list, #66 in FY2024 and #59 in FY2025; down 9 since Jul 2024–Jun 2025.
63 $946,678
Rank history: not on the FY2021–FY2023 lists, #59 in FY2024 and #60 in FY2025; down 8 since Jul 2024–Jun 2025.
64
Merz Pharmaceuticals LLC
$853,397
Rank history: not on the FY2021–FY2023 lists, #96 in FY2024 and not on the FY2025 list; up 23 since Jul 2024–Jun 2025.
65 $825,142
Rank history: not on the FY2021–FY2024 lists and #93 in FY2025; up 31 since Jul 2024–Jun 2025.
66 $795,559
Rank history: not on the FY2021–FY2024 lists and #77 in FY2025; new, not ranked in Jul 2024–Jun 2025.
67 $773,470
Rank history: not on the FY2021–FY2023 lists, #72 in FY2024 and #99 in FY2025; up 34 since Jul 2024–Jun 2025.
68 $719,635
Rank history: not on the FY2021–FY2023 lists, #58 in FY2024 and #72 in FY2025; up 6 since Jul 2024–Jun 2025.
69 $693,311
Rank history: not on the FY2021–FY2025 lists; up 26 since Jul 2024–Jun 2025.
70 $660,480
Rank history: #71 in FY2021, #72 in FY2022, #58 in FY2023, #93 in FY2024 and not on the FY2025 list; up 20 since Jul 2024–Jun 2025.
71 $637,204
Rank history: not on the FY2021–FY2024 lists and #56 in FY2025; down 23 since Jul 2024–Jun 2025.
72
Alexion Pharmaceuticals Inc
$628,701
Rank history: not on the FY2021–FY2023 lists, #62 in FY2024 and #96 in FY2025; up 27 since Jul 2024–Jun 2025.
73 $582,338
Rank history: not on the FY2021–FY2023 lists, #69 in FY2024 and not on the FY2025 list; up 8 since Jul 2024–Jun 2025.
74 $558,114
Rank history: #93 in FY2021, #90 in FY2022, #84 in FY2023 and not on the FY2024–FY2025 lists; up 94 since Jul 2024–Jun 2025.
75 $543,872
Rank history: not on the FY2021–FY2024 lists and #98 in FY2025; up 22 since Jul 2024–Jun 2025.
76 $513,180
Rank history: not on the FY2021–FY2024 lists and #80 in FY2025; up 8 since Jul 2024–Jun 2025.
77 $503,100
Rank history: #98 in FY2021 and not on the FY2022–FY2025 lists; up 138 since Jul 2024–Jun 2025.
78 $472,962
Rank history: not on the FY2021–FY2024 lists and #85 in FY2025; down 5 since Jul 2024–Jun 2025.
79 $458,224
Rank history: not on the FY2021–FY2024 lists and #91 in FY2025; up 104 since Jul 2024–Jun 2025.
80 $440,058
Rank history: not on the FY2021–FY2025 lists; up 38 since Jul 2024–Jun 2025.
81 $432,993
Rank history: not on the FY2021–FY2022 lists, #99 in FY2023 and not on the FY2024–FY2025 lists; up 43 since Jul 2024–Jun 2025.
82 $431,531
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Jul 2024–Jun 2025.
83
Grifols Diagnostic Solutions Inc. Through Grifols USA LLC
$413,287
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Jul 2024–Jun 2025.
84 $402,974
Rank history: not on the FY2021–FY2023 lists, #51 in FY2024 and #58 in FY2025; down 38 since Jul 2024–Jun 2025.
85 $402,717
Rank history: not on the FY2021–FY2022 lists, #6 in FY2023, not on the FY2024 list and #68 in FY2025; down 14 since Jul 2024–Jun 2025.
86 $401,005
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Jul 2024–Jun 2025.
87 $395,125
Rank history: not on the FY2021–FY2022 lists, #82 in FY2023, #90 in FY2024 and #70 in FY2025; down 17 since Jul 2024–Jun 2025.
88 $393,759
Rank history: not on the FY2021–FY2025 lists; up 109 since Jul 2024–Jun 2025.
89 $373,872
Rank history: not on the FY2021 list, #92 in FY2022, #41 in FY2023, #45 in FY2024 and not on the FY2025 list; up 11 since Jul 2024–Jun 2025.
90 $370,173
Rank history: not on the FY2021–FY2025 lists; up 24 since Jul 2024–Jun 2025.
91 $350,000
Rank history: not on the FY2021–FY2025 lists; up 38 since Jul 2024–Jun 2025.
92 $345,092
Rank history: not on the FY2021–FY2025 lists; up 70 since Jul 2024–Jun 2025.
93 $335,039
Rank history: not on the FY2021 list, #98 in FY2022, #97 in FY2023, not on the FY2024 list and #78 in FY2025; down 4 since Jul 2024–Jun 2025.
94 $318,917
Rank history: not on the FY2021–FY2025 lists; up 63 since Jul 2024–Jun 2025.
95
Ucb, Inc.
$308,413
Rank history: not on the FY2021–FY2025 lists; up 13 since Jul 2024–Jun 2025.
96
CSL Behring L.L.C.
$308,143
Rank history: not on the FY2021–FY2025 lists; up 19 since Jul 2024–Jun 2025.
97 $306,923
Rank history: not on the FY2021–FY2025 lists; up 104 since Jul 2024–Jun 2025.
98 $304,707
Rank history: not on the FY2021–FY2025 lists; up 37 since Jul 2024–Jun 2025.
99 $297,164
Rank history: not on the FY2021–FY2025 lists; up 13 since Jul 2024–Jun 2025.
100 $289,842
Rank history: not on the FY2021–FY2022 lists, #86 in FY2023 and not on the FY2024–FY2025 lists; up 95 since Jul 2024–Jun 2025.
Show 75 more

100 of 269 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $14.6 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Jul 2024–Jun 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325412 contractors in Jul 2025–Jun 2026?

1. Mckesson Corporation ($13.2B), 2. Emergent Biosolutions Inc. ($170M), 3. Phlow Corp. ($114M), 4. Exelan Pharmaceuticals Inc. ($107M), 5. Government of the United States ($93.5M), 6. Partner Therapeutics, Inc. ($50.2M), 7. Meridian Medical Technologies LLC ($46M), 8. Nighthawk Biosciences, Inc. ($45.6M), 9. Teva Pharmaceuticals Usa, Inc. ($42.1M), 10. Lantheus Holdings, Inc. ($39.1M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work